Literature DB >> 11408939

Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer.

G T Klus1, N Rokaeus, M L Bittner, Y Chen, D M Korz, S Sukumar, A Schick, Z Szallasi.   

Abstract

In previous studies using cDNA microarray analysis, we have identified an expressed sequence tag which is consistently down-regulated in six human breast tumor cell lines. In the current study, we have determined this tag to be part of the mRNA sequence of human desmocollin 3, a member of the cadherin superfamily of proteins and an integral component of desmosomes. Desmosomes are sites of adhesion between adjacent cells in layers of epithelia, as well as in some non-epithelial tissues, and play an important role in the maintenance of tissue structure. Northern analysis, quantitative real-time polymerase chain reaction assay and Western blot analysis showed that desmocollin 3 is present in normal and immortalized human mammary epithelial cells, but consistently exhibits a significant, and often complete, down-regulation in breast cancer cell lines and primary breast tumors, both at the mRNA and protein levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408939     DOI: 10.3892/ijo.19.1.169

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  Mammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium.

Authors:  Andrew J Ewald; Robert J Huebner; Hildur Palsdottir; Jessie K Lee; Melissa J Perez; Danielle M Jorgens; Andrew N Tauscher; Kevin J Cheung; Zena Werb; Manfred Auer
Journal:  J Cell Sci       Date:  2012-02-17       Impact factor: 5.285

Review 2.  Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer.

Authors:  Heather C Bruner; Patrick W B Derksen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

3.  No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer.

Authors:  Dominik Riss; Johannes Pammer; Matthaeus C Grasl; Alexandra Kaider; Sven Schneider; Boban M Erovic
Journal:  Wien Klin Wochenschr       Date:  2014-10-10       Impact factor: 1.704

4.  Loss of Desmocollin 3 in skin tumor development and progression.

Authors:  Jiangli Chen; Charlene O'Shea; James E Fitzpatrick; Maranke I Koster; Peter J Koch
Journal:  Mol Carcinog       Date:  2011-06-16       Impact factor: 4.784

5.  Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer.

Authors:  Peter T Simpson; Balvinder S Shoker; Roger Barraclough; Nigel Halliwell; Philip S Rudland; D Ross Sibson; Michael P A Davies
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

Review 6.  The role and function of cadherins in the mammary gland.

Authors:  Jennifer L Andrews; Alvin C Kim; Julie R Hens
Journal:  Breast Cancer Res       Date:  2012-02-08       Impact factor: 6.466

7.  Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.

Authors:  Rachel L Dusek; Jamie L Bascom; Hannes Vogel; Sylvain Baron; Alexander D Borowsky; Mina J Bissell; Laura D Attardi
Journal:  Breast Cancer Res       Date:  2012-04-20       Impact factor: 6.466

8.  Plakoglobin as a regulator of desmocollin gene expression.

Authors:  Etienne Tokonzaba; Jiangli Chen; Xing Cheng; Zhining Den; Radhika Ganeshan; Eliane J Műller; Peter J Koch
Journal:  J Invest Dermatol       Date:  2013-05-07       Impact factor: 8.551

9.  DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer.

Authors:  T Cui; Y Chen; L Yang; T Knösel; K Zöller; O Huber; I Petersen
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640

10.  Chemical genetic screen reveals a role for desmosomal adhesion in mammary branching morphogenesis.

Authors:  Kaitlin J Basham; Collin Kieffer; Dawne N Shelton; Christopher J Leonard; Vasudev R Bhonde; Hariprasad Vankayalapati; Brett Milash; David J Bearss; Ryan E Looper; Bryan E Welm
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.